Psych Atlanta
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Intranasal Esketamine to Maintain the Antidepressant Response to IV Racemic Ketamine (NCT04856124) | Psych Atlanta | 2018-09-01 |
Track Psych Atlanta automatically
Every clearance here is in the API, with alerts when new ones post.